CA Stock MarketDetailed Quotes

IPCI.H IntelliPharmaCeutics International Inc

Watchlist
  • 0.080
  • 0.0000.00%
15min DelayMarket Closed Mar 5 10:01 ET
2.65MMarket Cap-655P/E (TTM)

About IntelliPharmaCeutics International Inc Company

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

Company Profile

SymbolIPCI.H
Company NameIntelliPharmaCeutics International Inc
Founded2009
MarketTSX
Employees11
Fiscal Year Ends11-30
Address30 Worcester Road
CityToronto
CountryCAN
Zip CodeM9W 5X2
Phone+1 416 798-3001

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Isa Odidi, M.B.A.
  • Chairman of the Board, Chief Executive Officer and Co-Chief Scientific Officer
  • --
  • Dr. Amina Odidi
  • Acting Chief Financial Officer, Director, President, Chief Operating Officer and Co-Chief Scientific Officer
  • --
  • Dr. Patrick N. Yat
  • Vice President, Chemistry and Analytical Services
  • --
  • Dr. Norman Murray Betts, PhD
  • Independent Director
  • --
  • Shawn Graham
  • Independent Director
  • --
  • Bahadur Madhani, C.A.
  • Independent Director
  • --
Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data